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Abstract-We have investigated processing of monkey pro-opiomelanocortin (POMC) 
following transfection into heterologous neuronal Neuro 2A (N2A) cells. In several separately 
transfected stable cell lines (termed N2A/POMC24ike; n = 41, POMC was processed to BE only, 
by direct cleavage from the precursor. Thus, these cell lines did not produce DE in the orderly 
manner observed in the pituitary, that is, via the intermediate peptide BLPH. Analysis of one 
representative N2A/POMC2 cell line revealed that the extent of processing to /3E appeared to 
be negatively correlated with precursor expression level, suggesting that the processing 
enzyme(s) in these cells was present in limiting amounts. Northern analysis of PC1 and PC2, 
two recently cloned processing enzymes, showed that N2A/POMC2 cells expressed low levels 
of PC2 mRNA, but no detectable PC1 mRNA. These data suggest that (1) the order of 
processing observed in the pituitary is not exclusively determined by tertiary folding of the 
precursor, but rather by the complement of processing enzymes in a particular ceil, and (2) if 
PC2 is responsible for POMC processing in N2A/POMC2 cells, this enzyme, expressed in 
limiting amounts, appeared to show selectivity for the PE amino terminal processing site. 
Introduction in a number of peripheral tissues such as the pitu- 
Pro-opiomelanocortin (POMC) is the precursor of 
itary, pancreas and gastrointestinal tract and in neu- 
several different peptides with distinct biological 
rons in the brain emanating from the arcuate nucleus 
activities, including the stress hormone, adrenocor- 
and nucleus tractus solitarius (NTS). Although there 
ticotropic hormone (ACTH), and the opioid peptide, 
is only one POMC gene, the extent to which this 
SEndoTphinl-31 (PE).’ These component peptides are 
molecule is processed to yield different peptides 
excised from POMC by enzymatic cleavage at spe- 
varies depending on the tissue in which it is 
cific dibasic amino acid residues (e.g. lys-arg), a 
expressed. ‘J In addition, this precursor is processed 
process which is common to many precursor pro- 
in an orderly manner. For the purpose of this study, 
teins. POMC and its component peptides are found 
processing of the carboxy terminal half of the pre- 
cursor (comprising ACTH and SLPH), in the rat 
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species will be described (for review see ref. 2). The 





Fig. 1 Structure of POMC. This figure shows the POMC precursor and its component peptides, as well as the dibasic amino acid 
cleavage sites Harking each component peptide (e.g. KR = lys-arg). Certain cleavage sites labelled by circled numbers are referred 
to in the text. 
across tissues. In all tissues, the first sites to be 
cleaved within POMC (sites 1 and 2, Fig. 1) result 
first in the production of PLPH, followed by the pro- 
duction of ACTH. The extent to which subsequent 
cleavages occur then differs between different tis- 
sues. In the anterior pituitary, there is little further 
processing, except for cleavage of -30% of the 
PLPH molecules (at site 3, Fig. 1) to give yLPH and 
PE. Thus, the major carboxy terminal end products 
in this tissue are ACTH, /3LPH and some SE. In the 
intermediate pituitary, the POMC precursor is 
processed more extensively. ACTH is processed to 
yield ACTHI-1s and CLIP, and PLPH is fully 
processed to 7LPH and PE. In addition, the SE moi- 
ety is further processed at its carboxy terminus to 
truncated forms of this peptide. Other modifications 
in the intermediate pituitary include N-acetylation 
and C-terminal amidation of ACTHI-13 (resulting in 
a-melanocyte stimulating hormone; oMSH) and 
acetylation of PE peptides. In the brain, POMC pro- 
cessing appears to resemble that seen in the inter- 
mediate pituitary, in that the smaller peptides 
predominate. However, whereas in the arcuate 
nucleus non-acetylated j3E and olMSH are the major 
end products,3v4 in the NTS acetylated peptide forms 
predominate.5 
What is responsible for the orderly and tissue-spe- 
cific processing of POMC? While the orderly pat- 
tern of POMC maturation could either be a function 
of the conformational folding of the precursor, or a 
function of the cleavage site specificity of the POMC 
processing enzyme(s), the tissue-specific pattern of 
cleavage is presumably due to differential expres- 
sion or regulation of these enzymes. Two candidate 
neuropeptide processing enzymes, termed PC1 (or 
PC3) and PC2, have recently been cloned from pilu- 
itary and insulinoma libraries.“10 RNA transcripts of 
these clones have been shown to be present in a num- 
ber of tissues and cell lines, suggesting that they play 
a widespread role in precursor processing. With 
respect to POMC-producing tissues, it has been 
shown that anterior pituitary corticotrophs contain 
abundant PC 1 mRNA, but low levels of PC2 mRNA, 
while in the intermediate pituitary, PC2 message is 
more abundant than PC1 message.pJ1J2 These find- 
ings, in conjunction with POMC processing data, 
suggest that PC1 may be predominantly important 
in the initial cleavages of POMC resulting in the pro- 
duction of PLPH and ACTH, whilst PC2 may be pre- 
dominantly important in the later stages of 
processing resulting in the production of PE and 
aMSH. More direct data on the cleavage site speci- 
ficity of PC 1 and PC2 were obtained by co-express- 
ing the precursor with each enzyme in host cell 
lines.“J4 It was found that co-expression of POMC 
with PC1 resulted in the production of ACTH and 
PLPH, suggesting that PC1 favored cleavage at the 
amino terminal of ACTH and PLPH. In comparison, 
co-expression of the precursor with PC2 resulted in 
production of gE, CXMSH and an ACTH peptide 
extended with either joining peptide (JP)L3 or 
yLPH.14 The latter finding implies that PC2 has a 
broader range of cleavage site specificity than PC 1, 
since it cleaved more sites in the POMC precursor. 
However, it should be noted that the enzymes were 
highly expressed in these studies, due to virally- 
mediated DNA transfer, and that this condition may 
not be representative of the true cleavage site speci- 
ficity of PC1 and PC2 when expressed in their nat- 
ural tissues. 
An alternative approach to studying prohormone 
processing enzymes is to examine peptide end prod- 
ucts following transfection of precursor cDNA into 
a variety of heterologous cell lines. The results of 
these studies aid in determining those elements of 
processing controlled by the intrinsic precursor 
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structure, or by the complement of endogenous pro- 
cessing enzymes within a particular cell. This type 
of approach has been used to study processing of 
several propeptides. Is19 In this paper, we have exam- 
ined processing of POMC by the propeptide con- 
vertase(s) in a heterologous neuronal cell line, Neuro 
2A (N2A). This cell line, derived from a mouse 
neuroblastoma, does not synthesize endogenous 
POMC, and synthesis of other neuropeptides awaits 
demonstration. However, it has been shown that 
N2A cells can express transfected POMC cDNA and 
process the precursor to authentic PLPH and SE.16 
Given their neuronal origin and their ability to carry 
out post-translational processing, N2A cells 
appeared to be a good model for studying POMC 
processing in the brain. In pursuing this line of study, 
we have uncovered an unusual pattern of POMC 
processing. Our data show that several separately 
transfected N2A cell lines (which we have termed 
NZA/POMC2-like) processed POMC to SE only, by 
direct cleavage from the precursor; no SLPH was 
produced. This is a novel pattern of processing, not 
seen in tissues which normally produce POMC, and 
is in contrast to previous data showing that trans- 
fected N2A cells processed POMC to SLPH and 
SE.16 We have also observed the latter pattern ofpro- 
cessing in transfected N2A cell lines. However, for 
the purpose of this study, we have focussed on those 
N2A cell lines which processed POMC to PE only. 
Materials and methods 
Construction of expression vectors 
The POMC expression vector was constructed by 
subcloning an 870 base pair Hi&II-Sal1 cDNA 
restriction fragment, containing the monkey POMC 
coding sequence,*O into the cloning region of a plas- 
mid employing the inducible mouse metallothionein 
I promoter (pMtneo; obtained from Dr J. Dixon, 
University of Michigan, USA). This vector con- 
tained the gene coding for neomycin phosphotrans- 
ferase, confering resistance to the cytotoxic 
antibiotic G4 18 (geneticin). The resulting plasmid 
plus insert was termed pMtneo-POMC. 
Maintenance, transfection, and selection of cell 
lines 
N2A cells were obtained from ATCC (Rockville, 
MD, USA) and grown in Dulbecco’s Modified 
Eagles Medium (DMEM) supplemented with 10% 
fetal calf serum (GIBCO). The day prior to trans- 
fection, cells were plated at a density of 0.5 x lo6 
cells/plate in 10 cm tissue culture plates. 
Transfection was carried out by calcium phosphate 
co-precipitation, as described by Chen and 
Okayarna,Z’ using supercoiled plasmid DNA (20 pg) 
purified by cesium chloride gradient ultracentrifu- 
gation. 72 h after transfection, plasmid-containing 
cells were selected by addition of 0.5-0.75 mg/ml 
G418 to the media. Non-plasmid-containing cells 
died after 2-3 weeks exposure to G418. Following 
selection, individual cell clones were subcultured to 
separate flasks and maintained in 0.5 mg/ml G418. 
Cell cultures were passaged (subcultured) every 5-7 
d (P 1 representing the first passage following selec- 
tion of stable cell line). 16 h prior to harvesting, the 
metallothionein promoter was induced, and hence 
POMC expression was stimulated, by addition of 85 
pM ZnClz to the media. 
Extraction and molecular sieving of peptide prod- 
ucts 
N2A cells were scraped from tissue culture flasks, 
pelleted and homogenized in 0.2 M HCVacetone 
(1: 3) to extract peptide products. The cell extract 
was then passed over Sep-Pak Cl 8 cartridges 
(Waters) and the eluant dried by rotary evaporation. 
Lyophilized cell extracts (from 20-30 million cells) 
were then fractionated on a Sephadex G50 column 
(1.5 x 90 cm; Pharmacia) equilibrated in 1% formic 
acidO.Ol% BSA. The column was developed at a 
flow rate of 0.25 ml/min and 1.8 ml fractions were 
collected. The following molecular weight markers 
(10 mgsample volume) were used: Blue Dextran to 
mark the void volume, cobalt chloride to mark the 
total volume and 13 K cytochrome C. 
Measurement of POMC peptides by radioim- 
munoassay (‘A) 
Following Sephadex G50 column chromatography, 
individual fractions were assayed for different 
POMC-derived peptides using specific, well char- 
acterized RIA’s. The following antisera were used: 
Brenda (raised in our laboratory), directed against 
the midportion of the SE molecule (residues 17-27), 
with 100% cross-reactivity with POMC, PLPH, 
SEI-31, PEL-~~ and SE,-26; Nancy Beth (raised in our 
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laboratory), directed against the N-acetylated ter- 
minal of gE, with 100% cross-reactivity with all N- 
acetylated forms of PE; anti-PMSH (obtained from 
Dr N. G. Seidah, Clinical Research Institute of 
Montreal, Canada), directed against human PMSH, 
with 100% cross-reactivity with monkey POMC, 
SLPH, yLPH and PMSH; and anti-ACTH (raised in 
our laboratory), directed against residues 15-24 of 
this molecule, with no cross-reactivity with aMSH 
and 8% cross-reactivity with CLIP. The SE, N- 
Acetyl-PE and ACTH RIA’s were performed as 
described previously.5 The SMSH RIA was per- 
formed using the same conditions as the SE assay, 
with a final antibody dilution of 1: 50 000. 
HPLC analysis ofpeptides 
N2A/POMC2 cells were harvested as described 
above and homogenized in 0.2 M HCVacetone ( 1: 3). 
The cell extract was then clarified by centrifugation, 
dried by rotary evaporation, and resuspended in 
0.1% trifluoroacetic acid (TFA) with 0.00 1% BSA. 
This suspension was sieved through a Sephadex G50 
column equilibrated in 0.1% TFNO.00 1% BSA and 
the resulting fractions assayed for SE-immunoreac- 
tivity (SE-ir). Those fractions containing SE-sized 
immunoreactivity were pooled, dried, and resus- 
pended in 0.1% TFA. The samples were then sub- 
jected to weak cation exchange HPLC, as described 
by Dores et al.’ HPLC column fractions were dried 
and subjected to SE and N-Ace@-PE RIAs. 
Standards (human) used to identify SE peptides 
were: N-Acetyl SE~-Z~(ACPEW; +3 charges); N- 
Acetyl SEI-26 (A@-~6; +3 charges); /~EI-z~ (+4 
charges); SE1-26 (+4 charges); N-Ace@ PEI-31 
(AcSEIJI; +5 charges); PE1-31(+6 charges). It should 
be noted that while human SE1-3] differs from mon- 
key PEI-31 in its extreme carboxyl terminal end, both 
sequences have the same number of positive charges 
and will elute similarly on cation exchange HPLC. 
Northern analysis of PC1 and PC2 mRNA 
The presence of PC1 and PC2 mRNA in N2M 
POMC2 cells was assessed using specific, radio- 
labelled cRNA probes made from mouse PC1 and 
PC2 cDNA vectors (kindly donated by Drs R. Day 
and N. G. Seidah, Clinical Research Institute of 
Montreal, Canada). For comparison, these neuronal 
cells were probed alongside two other cell lines: 
AtT20, derived from a mouse corticotrophic tumor, 
and Rin m5F, derived from a rat insulinoma, both of 
which express PC 1 and PC2 ~RNAs.~,~,~ 
Radiolabelled antisense cRNA probes were gen- 
erated from cDNA’s corresponding to the 3’ cod- 
ing regions of PC 1 and PC2 by in vitro transcription 
with T7 polymerase in the presence of 250 pCi 
(cz-~~P)UTP. Total cytoplasmic mRNA was 
extracted from N2A, AtT20 and Rin m5F cells as 
described by Sambrook et a1.22 The RNA samples 
(50 pg) were size-fractionated on a 6% formalde- 
hyde/l .5% agarose gel, then passively transfered 
to a Nytran filter and air dried. The filter was pre- 
hybridized (2 h, 60°C) in 50% formaldehyde, 400 
mM NazPO+ 1 mM EDTA, 1 mg/ml BSA and 5% 
SDS, pH 7.0. Radiolabelled PC1 or PC2 probe 
was added to the hybridization buffer and incubated 
at 60°C for 18 h. The filter was then washed 
(0.1 x SSC, 0.1% SDS and 1 mM EDTA, 70°C for 
2 h) and exposed to X-ray film (Kodak x-Omat 
XARS). 
Results 
POMC processing in transfected N2A cells 
POMC peptide products, following extraction from 
transfected cells and separation by Sephadex G50 
chromatography, were assayed for peptide- 
immunoreactivity by specific RIAs. Separate trans- 
fections of N2A with pMtneo resulted in cell lines 
with two POMC processing patterns. One set of 
transfected cell lines (n = 3) processed POMC to 
SLPH and SE (data not shown), while several sep- 
arately transfected cell lines (termed N2A/POMC2- 
like; n = 4) processed POMC to SE only. The exact 
factors responsible for the two different processing 
patterns remain unclear. However, we have focussed 
our studies on the latter, novel pattern of process- 
ing, since the former processing pattern has been 
described before.16 
The processing pattern of passage 4 (P4) from a 
representative N2A/POMC2 cell line is shown in 
Figure 2a-c. Following SE RIA, two predominate 
SE-immunoreactive species were observed which 
corresponded to 3 1 K POMC and 3.5 K SE; virtu- 
ally no 11.5 K SLPH peak was observed. This pat- 
tern of processing may have resulted from rapid and 
complete processing of SLPH to SE, or from direct 





Fig. 2 POMC processing in NZA/POMCZ cells. This figure shows BE-ir (a), PMSH-ir (b) and ACTH-ir (c) chromatogmphic pro- 
files from a representative N2A/POMC2 cell line. The BE-immunoreactive profile (a) shows that POMC was processed to BE only; 
virtoally no BLPH was produced. When the same fractions were assayed for BMSH-ir (b), no yLPH or PMSH (BLPH cleavage prod- 
ucts) were observed, suggesting that PLPH was not an intermediate to BE synthesis and therefore that BE was cleaved directly from 
the precursor. ACTH RIA on these fractions (c) showed that POMC was not processed to ACTH_39. 
cleavage of gE from the POMC precursor. In order proceeded via the intermediate peptide PLPH. The 
to investigate this issue, we subjected the same set resulting PMSH sieving profile (Fig. 2b) exhibited 
of fractions to PMSH RIA, to look for the presence only one immunoreactive species, corresponding to 
or absence of yLPH and PMSH, two cleavage prod- 3 1 K POMC. Thus, the absence of yLPH or j3MSH 
ucts of PLPH. These peptides would have to exist in in this cell line suggests that SE was cleaved directly 
concentrations equimolar to PE if processing had from the precursor. 
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Table Proportions of PE-immunoreactive peptides in 
different passages from a representative N2AQOMC2 
cell line 
pE-ir (% of totul) Total @Sir 
Passage no. POMC PLpH /SE (jinoles/l@’ cells) 
3 31.4 - 68.6 5.3 
9 36.3 - 63.7 7.8 
26 60.4 - 39.6 12.9 
33 44.4 - 55.6 11.4 
ACTH RIA on these N2A/POMC2 cells resulted 
in one immunoreactive peak, eluting in the position 
of the POMC precursor (Fig. 2~). This peak pre- 
sumably consisted of intact POMC precursor and 
the peptide fragment remaining following cleavage 
of PE (-28 IQ. The absence of any ACT&_sg-sized 
immunoreactivity in this cell line confirmed that the 
carboxy terminal processing site of ACTH was not 
cleaved, as predicted from the PE and PMSH pro- 
files from the same cell line (Fig. 2a & b), and also 
implies that the amino terminal processing site of 
ACTH was not cleaved. 
Cell lines exhibiting N2AiPOMCZlike process- 
ing patterns remained stable with continuous pas- 
saging, consistently producing PE only. This finding 
is illustrated in Table for a second N2A/POMC2- 
like cell line. 
HPLC analysis of /SE-ir 
PE-sized material was analyzed in a representative 
N2A/POMC2 cell line by weak cation exchange 
HPLC analysis. Using a mid-portion PE RIA 
(Brenda), four peaks of immunoreactivity were 
detected(Fig. 3) which correspondedto AcPEl-27 (+3 
charges), PEl-27 (+4 charges), AcPEl-sl (+5 charges) 
and /3ElW3, (+6 charges). Analysis of the same frac- 
tions with a RIA which recognized N-acetylated 
derivatives of PE (Nancy Beth) confirmed that the 
peaks of immunoreactivity eluting in fractions 
28-35 and 57-61 represented AcPEl-27 and AcPEl-31 
respectively (shaded peaks in Fig. 3). 
In this particular cell line, 62% of the PE-ir cor- 
responded to PElT2, peptides (PEG27 and AC&Z), 
while 21% corresponded to full length peptides 
(PEG31 and AcPE~_x). It should be noted, however, 
that HPLC analysis of PE-sized material from a dif- 
ferent N2AROMC2 cell line resulted in a profile 
where the majority of the immunoreactivity (69%) 
SO 
fraction no. 
Fig. 3 Ion exchange HPLC analysis of PE-ir in N2AIPOMC2 
cells. PE-sized material fromN2AfpOMC2 cells was dried, resus- 
pended in 0.1% TFA and chromatographed on a TSK CM-2SW 
ion exchange column as described in Methods. (a) Chro- 
matographed BE-sized material was assayed with a mid-portion 
directed DE antiserum (Brenda: solid line) and the N-Acetvl DF 
antiser& (Nancy Be&; shadeh areas). The elution positik’of 
the following standards is shown: Ac~EL-z~ (+3 charges); PEl-27 
(+4 charges); AC&~, (+5 charges); PEI-3, (+6 charges). 
corresponded to full length PE peptides, while only 
25% represented PE1_27 peptides. In both cases, more 
of the truncated peptide, PEW, was present in acety- 
lated form (> 70%) than the full length peptide 
(-50%). 
Correlation of POMC processing to /3E with pre- 
cursor expression level 
The effect of precursor expression level on pro- 
cessing to PE is shown in Figure 4. In this analysis, 
processing to /3E was defined as the percentage that 
/3E peptide represented of total POMC expression 
(that is, total PE-ir; the sum of the amount of POMC, 
PLPH and BE peptides in fmoles/106 cells). This 
graph represents data from several passages of a rep- 
resentative N2A/POMC2 cell line (see Table for 
data). The data show that the higher the level of 
POMC expression, the lower the degree of process- 
ing to PE (Fig. 4, r = -0.93). These data suggest that 
the processing enzyme in this N2A/POMC2 cell line 
was present in limiting amounts with respect to the 
amount of precursor expressed. 
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Fig. 4 Correlation of POMC processing to 8E with precursor 
expression level. POMC processing to 8E (as a percentage oftotal 
BE-ir) was plotted against POMC expression level (i.e. total 8E- 
ir, the sum of the amount of POMC, 8LPH and 8E in linoles/l O6 
cells) for several passages from a representative N2AiPOMC2 
cell line (data shown in Table). The correlation coefficient (r 
value) is indicated. The graphs show that those passages with 
higher levels of POMC expression exhibited less processing to 
8E peptide. 
PC1 and PC2 mRh!A expression in N2A/POMC2 cells 
PC 1 and PC2 mRNA expression were determined in 
untransfected and transfectedN2A cells, AtT20 cells 
and Rin m5F cells by Northern gel analysis (Fig. 5). 
With respect to PC1 mRNA, one major band was 
observed in AtT20 and Rin m5F lanes which 
migrated just above the 2.4 kilobase (kb) marker. 
PC1 transcripts were most abundant in AtT20 cells 
and very low in Rin m5F cells. There was no 
detectable PC 1 mRNA in untransfected N2A cells or 
in N2A/POMC2 cells. This transcript remained 
undetected following Northern analysis of poly(A+) 
mRNA from these cells (data not shown). Analysis 
of PC2 mRNA in the different cell types revealed 
one major band, migrating at a slightly lower mole- 
cular weight than PC 1. PC2 mRNA was abundant in 
Rin m5F cells, but present in low amounts in AtT20 
cells. Both untransfected N2A and N2A/POMC2 
cells expressed low levels of PC2 mRNA. 
Discussion 
In this paper we have shown that several stably trans- 
fected N2A cell lines (termed N2A/POMC2-like) 
processed transfected monkey POMC to PE-sized 
products only; this appeared to occur via direct 
cleavage of PE from the precursor since no biosyn- 
thetic intermediates or peptide products from any 
other region of the precursor could be detected. This 
is in contrast to several separately transfected stable 
cell lines where POMC was processed to PLPH and 
PE, as described previous1y.16 The reason for the two 
different processing patterns is unclear and has not 
been addressed in this study. Instead, we have 
focussed on the novel processing pattern seen in 
N2AROMC2-like cell lines. In this type of cell line 
we found that (a) the PE-sized material corre- 
PC1 PC2 
188 
Fig. 5 Northern analysis of PC1 and PC2 mRNA in N2A/ 
POMCZ cells: comparison with untransfected N2A, AtT20 and 
Rin m5F cells. Total cytoplasmic mRNA was extracted from the 
above cell lines, size-fractionated on an agarose gel and trans- 
fered to a Nytran filter. PC1 and PC2 mRNA were detected by 
hybridizationtoradiolabelledPC1 orPC2cRNAprobesandvisu 
alized by exposure to X-ray film. Both PC1 and PC2 mRNA 
migrated just above the 2.4 kb marker, although PC2 mRNA was 
slightly smaller in size than PC1 mBNA. N2APOMC2 cells 
expressed low levels of PC2 mRNA, but no detectable PC1 
mENA. 
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sponded to elution of BE standard peptides by HPLC 
analysis, (b) processing to PE appeared to be depen- 
dent on the level of POMC expression, and (c) that 
these cells expressed low levels of PC2 mRNA, but 
no detectable PC1 mRNA. 
Ion exchange HPLC analysis of PE-sized mater- 
ial in N2A/POMC2 cells demonstrated the presence 
of authentic PEI-31 and PE1_2, peptides. The ratio of 
truncated/till length peptides varied (from 62% to 
25%) in two cell lines analysed. This variation was 
probably due to differences in the ratio of transfected 
precursor to processing enzyme, but this remains to 
be tested. With respect to full length /3E-ir, -50% 
appeared to be N-acetylated, whereas somewhat 
more of the truncated peptide (~70%) was present 
in acetylated form. A similar phenomenon was 
observed for acetylation of PE peptides in rat inter- 
mediate pituitaryz3 and caudal medulla tissue.5 This 
is probably due to acetylation being a more rapid 
process than carboxy-terminal truncation, such that 
PEl_31 is acetylated first and then cleaved to PEl-27 
and PEGz.~ That we observed acetylated and trun- 
cated forms of PE differs from results obtained by 
Noel and co-workers16 who did not observe the pres- 
ence ofthese peptides. While the explanation for this 
is not clear, it is possible that different N2A sublines 
may possess different biochemical features. 
The finding that N2A/POMC2 cells produced PE 
only, by direct cleavage from the precursor, implies 
that the processing enzyme in these cells favored 
cleavage of the amino terminal processing site of SE 
(site 3, Fig. 1) above other cleavage sites. This pat- 
tern of processing is unlike that seen in POMC-pro- 
ducing tissues and is indicative of a different 
complement of processing enzymes to these tissues. 
This fmding also suggests that the sequential pro- 
cessing to PE observed in the pituitary (that is, 
through PLPH) is unlikely to be exclusively deter- 
mined by the tertiary conformation of the precursor, 
but rather is controlled predominantly by the pro- 
cessing enzymes themselves. Analysis of process- 
ing in several passages from a representative 
N2A@OMC2 cell line showed that the higher the 
level of precursor expression the lower the extent of 
processing to PE. The phenomenon of higher levels 
of precursor expression (and hence lower 
enzyme/precursor ratio) causing a decrease in pro- 
cessing has been observed beforeZ5 and suggests that 
the amount of POMC expression in N2AROMC2 
cells may have saturated the N2A processing 
enzyme, that is, that the processing enzyme was pre- 
sent in limiting amounts. 
With the cloning of PC1 and PC2, we were able 
to look for the expression of mRNAs coding for 
these enzymes in transfected N2A cells. As positive 
controls, we examined mRNA expression in AtT20 
and Rin m5F cells, both of which express PC1 and 
PC2 mRNA and are known to process peptide pre- 
cursors. AtT20 cells express endogenous POMC 
and process this precursor to similar end products as 
those found in the anterior pituitary,* that is, PLPH, 
ACTH and some PE. These cells, like anterior pitu- 
itary corticotrophs, contain abundant PC1 mRNA 
and low levels of PC2 mRNA.6 Rin m5F cells, on 
the other hand, have been shown to process trans- 
fected POMC to a greater extent than anterior pitu- 
itary corticotrophs, the major end products (SE and 
crMSH) being similar to those found in the interme- 
diate pituitary (ref. 26 and N. C. Day, unpublished 
data). With respect to enzyme mRNA expression in 
Pin m5F cells, both PC1 and PC2 were cloned from 
this cell line.g Although the relative abundance of 
these mRNAs was not reported, it has been shown 
that mouse and human insulinomas express abun- 
dant PC2 mRNA, but low levels of PC1 mRNA.Q 
Our analysis of PC 1 and PC2 mRNA expression 
in AtT20 cells confirmed the above findings, show- 
ing that these cells contained an abundance of PC1 
compared to PC2 mRNA and that these transcripts 
were similar in size to those reported previously.6J 
In contrast, Rin m5F cells expressed abundant PC2 
and very low levels of PC1 mRNA, indicating that 
rat insulinoma cells express these enzymes in simi- 
lar proportions as mouse and human insulinoma 
cells6J Analysis of mRNA expression in 
N2A/POMC2 cells revealed that this cell line 
expressed low levels of PC2 mRNA, but contained 
no detectable PC 1 mRNA (even following Northern 
analysis of poly(A+) mRNA from transfected cells; 
data not shown). The PC2 transcript in N2A/ 
POMC2 cells was similar in size and abundance as 
that seen in AtT20 cells. 
The fIndings of the present study lead to some 
implications about the cleavage site specificity of 
PC2 and the enzyme complements required for pro- 
cessing to different POMC peptides. Previous stud- 
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ies of the cleavage site specificity of PC1 and PC2 
have involved co-expression of the enzymes with 
POMC in host cell lines, using vaccinia virus-medi- 
ated DNA transfer.‘3J4 The results of these studies 
suggested that PC1 favored cleavage at the amino 
terminal of ACTH and PLPH, while PC2 exhibited 
a broader range of specificity, cleaving additional 
sites in the POMC precursor. From these studies, the 
question arises as to the purpose of expressing PC 1 
in POMC-producing tissues, when PC2 appears to 
possess the ability of cleaving those sites which PC1 
cleaves, as well as additional sites. We would like 
to suggest that the high level of expression afforded 
with the vaccinia virus method of transfection may 
not have been representative of the cleavage site 
specificity of PC2 when expressed in limiting 
amounts. In our studies, the POMC processing 
enzyme(s) in N2A/POMC2 cells did appear to be 
expressed in limiting amounts. Furthermore, expres- 
sion of PC2 mRNA in these cell lines suggests that 
this propeptide convertase may have been responsi- 
ble for the observed pattern of processing. It follows 
then that in the conditions prevailing in 
N2APOMC2 cells, PC2 may have favored cleav- 
age of the PE amino terminal processing site above 
other processing sites. Thus, this enzyme may 
indeed exhibit greater specificity than previously 
reported in POMCiPC2 co-expression studies.L3J4 
Our findings also suggest that production of j3E via 
the PLPH intermediate, as occurs in the pituitary,24*27 
probably requires the action of an additional 
enzyme, such as a PCl-like enzyme, which favors 
cleavage at the amino terminal processing site of 
PLPH. In support of this hypothesis is the observa- 
tion that PC 1 is expressed alongside PC2 in POMC- 
producing cells of the anterior and intermediate 
pituitary (albeit in different ratios), suggesting that 
PC 1 is required in addition to PC2 in order to achieve 
the orderly pattern of POMC maturation observed 
in these tissues. 
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